Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 324 of 5804
-
Gut bacteria boost? new trial combines probiotic with cancer therapy for rectal tumors
Disease control Recruiting nowThis prospective, single-center, randomized controlled trial aims to assessing the efficacy and safety of neoadjuvant chemoradiation plus Tislelizumab (PD-1 inhibitor) with or without Probio-M9 and subsequent TME surgery, by comparing assorted endpoints between two experiment gro…
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Exoskeleton breakthrough: walk Hands-Free after spinal injury?
Symptom relief Recruiting nowThis study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Phase: NA • Sponsor: Wandercraft • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Magic mushrooms take on PTSD: early trial begins
Symptom relief Recruiting nowThis study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.
Phase: PHASE1 • Sponsor: Suzanne "Sue" Sisley MD • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Smart insulin pump takes on diabetes and stomach paralysis
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Phase: NA • Sponsor: Viral N. Shah • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New Dual-Target CAR t therapy aims to control multiple myeloma early
Disease control Recruiting nowThis is a phase 1b study evaluating if BMS-986453 is safe and effective in treating people who have newly diagnosed multiple myeloma after completing initial therapy (induction) when a stem cell transplant is not intended.
Phase: PHASE1 • Sponsor: Susan Bal • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New weekly shot aims to ease arthritic knee pain and shed pounds
Symptom relief Recruiting nowThe YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New injection could help sleep apnea without CPAP
Disease control Recruiting nowThe aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gout drug pegloticase gets a shot in the arm: new subcutaneous option tested
Disease control Recruiting nowThe primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus pegloticase 8 mg intravenously (IV) every two weeks with MTX on the response rate during Month 6, as measured by the sustained nor…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Botox in the womb: a new hope for crippling period pain?
Symptom relief Recruiting nowThe objective of the study is to evaluate the global impression of improvement at 3 months following intramyometrial botulinum toxin injections via hysteroscopy in women with severe primary dysmenorrhea who have failed first-line medical treatment, compared to intramyometrial pla…
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Electric suit may help people with spinal cord injury walk better
Disease control ENROLLING_BY_INVITATIONSpinal cord injuries (SCI) impair neural communication, leading to difficulties in walking due to muscle weakness, altered reflexes, and impaired muscle activation below the injury. Functional electrical stimulation (FES) has been shown to enhance voluntary control, strength, and…
Phase: NA • Sponsor: Stichting Reade • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for melanoma patients who Don't respond to standard immunotherapy
Disease control Recruiting nowThis clinical trial is for patients with stage 3 cutaneous melanoma and patients with mucosal melanoma who are able to have surgery to remove all tumour deposits. To improve the chance that melanoma will not recurr, new experimental combinations of a type of treatment called immu…
Phase: PHASE2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New eye drug could mean fewer shots for Diabetes-Related vision loss
Disease control Recruiting nowThis is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Hope for MSA: new drug aims to slow rare brain disease
Disease control Recruiting nowThe purpose of this study is to evaluate whether MSA-01 slows the progression of multiple system atrophy (MSA) and to assess its safety. The primary question is: • Does MSA-01 slow the progression of motor impairment as measured by UMSARS Part 2 score? Participants will be ran…
Phase: PHASE3 • Sponsor: Tokyo University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for lupus patients: drug trial targets kidney damage
Disease control Recruiting nowThe goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic lupus erythematosus and active lupus nephritis. It will also learn about the safety of cenerimod. The main questions it aims to ans…
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New device aims to fix lingering aortic tears after emergency surgery
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled clinical study. A total of 198 eligible subjects will be enrolled and randomly assigned in a 1:1 ratio to either the Study Group or the Control Group. Subjects in the Study Group will receive surgical treatment using the s…
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat throat cancer
Disease control Recruiting nowThis is a single-center, prospective, single-arm, phase II clinical study, to evaluate the therapeutic efficacy and safety of envafolimab combined with chemoradiotherapy and recombinant human endostatin in patients with locally advanced nasopharyngeal carcinoma.
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pneumonia vaccine VAX-31 aims to boost protection in older adults
⭐️ VACCINE ⭐️ OngoingThe study will evaluate the safety, tolerability, and immunogenicity of VAX-31 in adults ≥50 years of age.
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
New hope for hard-to-treat myeloma: experimental drug enters phase 2 trial
Disease control Recruiting nowThe purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells called a plasma cell. Cancer is called relapsed if it comes back after treatment …
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Brain Scan-Guided procedure could boost stroke recovery
Disease control Recruiting nowThe investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to evaluate the efficacy and safety of perfusion-guided endovascular treatment (EVT) compared to standard medical care for patients with acute ischemic stroke…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Promising cocktail targets brain cancer
Disease control Recruiting nowThis is a multicenter, open-label, single-arm, prospective clinical study of PD-1 inhibitor combined with rituximab, methotrexate, and orelabrutinib (PD-1i+RMO) in the treatment of newly diagnosed primary central nervous system lymphoma (ND-PCNSL) and secondary central nervous sy…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC